Where does ABK Biomedical's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across ABK Biomedical's 4 recorded funding rounds.

Premier Alternatives

ABK Biomedical

Halifax, Canada · Founded 2012 · Privately Held (backing)

Developer of a microsphere product designed to improve the treatment of hypervascular tumors. ABK Biomedical is based in Halifax, Canada and was founded in 2012. Its last reported valuation was $73 million in Dec 2022. It has raised $122 million across 4 recorded rounds; the latest was a $2.6 million seed round in Oct 2025.

Last reported valuation

$73.0M

Oct 2026

Priced at

—

Total raised

$121.7M

Last round

Seed Round

Oct 2025

Cap table — not yet on record

ABK Biomedical's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of ABK Biomedical with a free account

·The complete investor list: 11 names
·Watch ABK Biomedical: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about ABK Biomedical

Where does ABK Biomedical's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across ABK Biomedical's 4 recorded funding rounds.